Suppr超能文献

人肝脏和十二指肠中R(-)-阿扑吗啡的硫酸化作用及其受甲芬那酸、水杨酸和槲皮素的抑制作用。

Sulfation of R(-)-apomorphine in the human liver and duodenum, and its inhibition by mefenamic acid, salicylic acid and quercetin.

作者信息

Vietri M, Vaglini F, Pietrabissa A, Spisni R, Mosca F, Pacifici G M

机构信息

Department of Neurosciences, Section of Pharmacology, Via Roma 55, I-56126 Pisa, Italy.

出版信息

Xenobiotica. 2002 Jul;32(7):587-94. doi: 10.1080/00498250210131581.

Abstract
  1. The aims were to study the sulfation of R-(-)-apomorphine (hereafter apomorphine) in the human liver and duodenum, and to study the rate of inhibition of apomorphine sulphation by mefenamic acid, salicylic acid and quercetin also in the human liver and duodenum. 2. A rapid and sensitive method was developed to measure the sulfation rate of apomorphine in the human liver and duodenum. The method was based on the use of 0.4 micro M 3'-phosphoadenosine-5'-phosphosulfate-[(35)S] (PAPS) and 50 micro M apomorphine. The unreacted PAPS was precipitated with barium hydroxide, barium acetate and zinc sulfate. 3. The rate of apomorphine sulfation (mean +/- SD and median) was 261 +/- 82 and 242 pmol min(-1) mg(-1), respectively (liver), and 433 +/- 157 and 443 pmol min(-1) mg(-1), respectively (duodenum). The apomorphine sulfation rate was higher in the duodenum than in the liver (p = 0.0005). 4. Apomorphine sulfation was correlated with SULT1A1 activity in the liver (r(2) = 0.363, p = 0.005) and duodenum (r(2) = 0.494, p = 0.0005), but it did not correlate with SULT1A3 activity both in the liver and duodenum. 5. The K(m) estimate of apomorphine sulfation rate was 20 +/- 3.6 (liver) and 6.5 +/- 0.2 microM (duodenum, p = 0.024), and the V(max) estimate was 248 +/- 99 (liver) and 636 +/- 104 pmol min(-1) mg(-1) (duodenum, p = 0.018). 6. Mefenamic acid, salicylic acid and quercetin were potent inhibitors of apomorphine sulfation rate in the liver, and the IC(50) estimates were 16 +/- 0.2 nM, 54 +/- 8.6 microM and 18 +/- 2.8 nM, respectively. These compounds were poor inhibitors of apomorphine sulfation in the duodenum. 7. Apomorphine is sulfated by the human liver and duodenum, the highest activity being associated with the duodenum. The K(m) of apomorphine sulfotransferase is in the order of micro M both in the liver and duodenum. The non-steroidal anti-inflammatory drug mefenamic acid and the natural flavonoid quercetin inhibit the hepatic sulfation of apomorphine with an IC(50) in the order of nM.
摘要
  1. 目的是研究R-(-)-阿扑吗啡(以下简称阿扑吗啡)在人肝脏和十二指肠中的硫酸化作用,并研究甲芬那酸、水杨酸和槲皮素对人肝脏和十二指肠中阿扑吗啡硫酸化作用的抑制率。2. 开发了一种快速灵敏的方法来测定人肝脏和十二指肠中阿扑吗啡的硫酸化速率。该方法基于使用0.4微摩尔3'-磷酸腺苷-5'-磷酸硫酸酯-[(35)S](PAPS)和50微摩尔阿扑吗啡。未反应的PAPS用氢氧化钡、乙酸钡和硫酸锌沉淀。3. 阿扑吗啡硫酸化速率(平均值±标准差和中位数)在肝脏中分别为261±82和242皮摩尔·分钟(-1)·毫克(-1),在十二指肠中分别为433±157和443皮摩尔·分钟(-1)·毫克(-1)。十二指肠中阿扑吗啡硫酸化速率高于肝脏(p = 0.0005)。4. 阿扑吗啡硫酸化与肝脏(r(2) = 0.363,p = 0.005)和十二指肠(r(2) = 0.494,p = 0.0005)中的SULT1A1活性相关,但与肝脏和十二指肠中的SULT1A3活性均无相关性。5. 阿扑吗啡硫酸化速率的K(m)估计值在肝脏中为20±3.6,在十二指肠中为6.5±0.2微摩尔(p = 0.024),V(max)估计值在肝脏中为248±99,在十二指肠中为636±104皮摩尔·分钟(-1)·毫克(-1)(p = 0.018)。6. 甲芬那酸、水杨酸和槲皮素是肝脏中阿扑吗啡硫酸化速率的有效抑制剂,IC(50)估计值分别为16±0.2纳摩尔、54±8.6微摩尔和18±2.8纳摩尔。这些化合物在十二指肠中对阿扑吗啡硫酸化的抑制作用较弱。7. 阿扑吗啡在人肝脏和十二指肠中被硫酸化,十二指肠中的活性最高。肝脏和十二指肠中阿扑吗啡硫酸转移酶的K(m)均在微摩尔级别。非甾体抗炎药甲芬那酸和天然黄酮类化合物槲皮素抑制阿扑吗啡的肝脏硫酸化,IC(50)在纳摩尔级别。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验